Open randomized comparative twelve-week study of lithium and valproate in manic episode

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 109, Issue 11, 2009, Pages 47-52

  Mosolov, S N ^a   Kostyukova, E G ^a   Kapiletty, S G ^a   Belenkaya, D V ^a   Shafarenko, A A ^a   Fedotov, D D ^a  

^a NONE

Author keywords

Bipolar disorder; Lithium; Mania; Valproate

Indexed keywords

LITHIUM CARBONATE; VALPROIC ACID; TRANQUILIZER;

ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MANIA; MONOTHERAPY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAUSEA; SCORING SYSTEM; SIDE EFFECT; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREMOR; VITAL SIGN; XEROSTOMIA; YOUNG MANIA RATING SCALE; ADOLESCENT; AGED; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG COMBINATION; FOLLOW UP; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TIME;

ADOLESCENT; ADULT; AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME; VALPROIC ACID; YOUNG ADULT;

EID: 77949317610     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Berk M., Ichim L., Brook S. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int Clin Psychopharmacol 1999; 14: 339-343.
2. Bowden C., Brugger A., Swann A. et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The depakote Mania Study Group. Jama 1994; 271: 918-924.
3. Bowden C. Key treatment studies of lithium in manic-depressive illness: efficacy and side effects. J Clin Psychiat 1998; 59: Suppl 6: 13-19, 20 (discussion).
4. Bowden C., Calabrese J., Gyulai L., Wassef A. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Jama 2000; 271: 918-924.
5. Bowden C., Grunze H., Mullen J. et al. A randomized, double-mind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiat 2005; 66: 111-121.
6. Bowden C., Swann A., Calabrese J. et al. A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiat 2006; 67: 1501-1510.
7. Calabrese J., Woyshville M. Lithium Therapy: limitations and alternatives in the treatment of bipolar disorders. Ann Clin Psychit 1995; 7: 103-112.
8. Freeman T., Clothier J., Pazzaglia P. et al. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiat 1992; 149: 108-111.
9. Goodwin G. Evidence -based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2003; 17: 149-173, discussion 147.
10. Grunze H., Kasper S., Goodwin G. et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. World J Biol Psychiat 2003; 4: 5-13.
11. th American Psychiatric Association Annual Meeting. USA, Philadelphia, PA, May 18-23, 2002.
12. Lambert P., Carraz G., Borselli S., Carbel S. Action neuropsychotrope d un nouvel antiepileptique: le Depamide. Ann Med Psychol (Paris) 1966; 124: 707-710.
13. Montgomery S., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiat 1979; 134: 382-389.
14. Pope H., MCelroy S., Keck P., Hudson J. Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychit 1991; 48: 62-68.
15. Schou M. Normothymics, «mood-normalizers». Are lithium and imipramine drugs specific for affective disorders? Br J Psychiat 1963; 109: 10: 803-809.
16. Spearing M., Post R., Leverich G. et al. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiat Res 1997; 73: 159-171.
17. Suppes T., Dennehy E., Swann A. et al. Report of Texas Consensus Conferens Panel on medication treatment of bipolar disorder. J Clin Psychiat 2002; 63: 288-299.
18. Swann A. Prediction of treatment response in acute mania: controlled clinicaltrials with divalproex. Encephale 2001; 27: Suppl 3: 277-279.
19. Tohen M., Baker R., Altshuler L. et al. Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiat 2002; 159: 1011-1017.
20. Yatham L., Kennedy S., O'Donnovan C. et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Dis 2006; 8: 721-739.
21. Young R., Biggs J., Ziegler V., Meyer D. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiat 1978; 133: 429-435.
22. Zajecka J., Weisler R., Sachs G. et al. A comparison of the efficacy? Safety? And tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiat 2002; 63: 1148-1155.